Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05008185 · ClinicalTrials.gov registry record
Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation
A clinical trial of Neuroma, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT05008185 is a study of Neuroma that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 80 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05008185, a study of Neuroma, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
Conditions Studied
Interventions
- PROCEDURE Regenerative Peripheral Nerve Interface (RPNI) surgery
- PROCEDURE Traction Neurectomy
Study Locations (2)
Maryland
- The Curtis National Hand Center at Medstar Union Memorial Hospital - Baltimore
Michigan
- University of Michigan Plastic Surgery - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2025-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05008185
The ClinicalTrials.gov registry entry for NCT05008185 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuroma appearing as the primary indexed condition, and to 2 interventions - of which Regenerative Peripheral Nerve Interface (RPNI) surgery is the first listed.
NCT05008185 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT05008185 about?
NCT05008185 is a clinical study titled "Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation". This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
What is the current status of trial NCT05008185?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2021-10-05. Estimated completion is 2025-08.
What conditions does trial NCT05008185 study?
This clinical trial studies the following conditions: Neuroma.
What interventions are being tested in trial NCT05008185?
The interventions under investigation include: Regenerative Peripheral Nerve Interface (RPNI) surgery (PROCEDURE), Traction Neurectomy (PROCEDURE).
Who is sponsoring clinical trial NCT05008185?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05008185 being conducted?
This trial has 2 study locations across Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuroma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.